Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants
- PMID: 730368
- PMCID: PMC422180
- DOI: 10.1128/iai.22.2.473-479.1978
Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants
Abstract
Coagulase-negative and deoxyribonuclease-negative mutants were isolated from Staphylococcus aureus BB by treatment with N-methyl-N'-nitro-N-nitrosoguanidine. Comparison of virulence (50% lethal dose) to mice of these six mutant strains and S. aureus BB was determined by both intravenous and intraperitoneal routes. The ratios of the 50% lethal dose of coagulase-negative mutants to that of the parental strain S. aureus BB ranged from 201 to 403 for intravenous infection and 30.7 to 52.7 for intraperitoneal infection. The virulence of deoxyribonuclease-negative mutants was essentially the same as that of S. aureus BB. When mice were immunized subcutaneously with live S. aureus BB or its deoxyribonuclease-negative mutants, the resulting protection against the intravenous challenge of S. aureus BB was remarkable. The ratios of the 50% lethal dose for the mice that were immunized by these strains to that for the untreated mice extended from 40.1 to 60.6 for intravenous infection and 6.61 to 11.5 for the intraperitoneal route. However, no effect against S. aureus BB challenge was shown in the mice that were immunized with coagulase-negative mutants.
Similar articles
-
Avirulence and immunogenicity in mice of a bovine mastitis Staphylococcus aureus mutant.Can J Vet Res. 1998 Oct;62(4):293-8. Can J Vet Res. 1998. PMID: 9798096 Free PMC article.
-
Effect of highly purified coagulase and culture filtrate on virulence and immunity of a coagulase-negative mutant of staphylococcus aureus BB.Infect Immun. 1983 Mar;39(3):1236-42. doi: 10.1128/iai.39.3.1236-1242.1983. Infect Immun. 1983. PMID: 6840839 Free PMC article.
-
Isolation and virulence of a caseinase- and bound coagulase-deficient mutant of Staphylococcus aureus BB.J Infect Dis. 1984 Apr;149(4):538-43. doi: 10.1093/infdis/149.4.538. J Infect Dis. 1984. PMID: 6373962
-
Prospects for active and passive immunization against Staphylococcus aureus.Pediatr Infect Dis J. 2006 Feb;25(2):167-8. doi: 10.1097/01.inf.0000199887.18267.9a. Pediatr Infect Dis J. 2006. PMID: 16462297 Review. No abstract available.
-
[Infections caused by staphylococci. The human as a source of infection for S. aureus and coagulase negative staphylococci].Fortschr Med. 1991 Jul 30;109(22):437-40. Fortschr Med. 1991. PMID: 1937322 Review. German.
Cited by
-
Avirulence and immunogenicity in mice of a bovine mastitis Staphylococcus aureus mutant.Can J Vet Res. 1998 Oct;62(4):293-8. Can J Vet Res. 1998. PMID: 9798096 Free PMC article.
-
Virulence factors among gram-positive bacteria in experimental endocarditis.Infect Immun. 1994 Jun;62(6):2143-8. doi: 10.1128/iai.62.6.2143-2148.1994. Infect Immun. 1994. PMID: 8188334 Free PMC article. Review. No abstract available.
-
Effect of highly purified coagulase and culture filtrate on virulence and immunity of a coagulase-negative mutant of staphylococcus aureus BB.Infect Immun. 1983 Mar;39(3):1236-42. doi: 10.1128/iai.39.3.1236-1242.1983. Infect Immun. 1983. PMID: 6840839 Free PMC article.
-
Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads.Infect Immun. 1997 Feb;65(2):466-71. doi: 10.1128/iai.65.2.466-471.1997. Infect Immun. 1997. PMID: 9009298 Free PMC article.
-
Quercetin protects rats from catheter-related Staphylococcus aureus infections by inhibiting coagulase activity.J Cell Mol Med. 2019 Jul;23(7):4808-4818. doi: 10.1111/jcmm.14371. Epub 2019 May 15. J Cell Mol Med. 2019. PMID: 31094081 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources